One of the most common questions I get from patients considering ketamine therapy is simple: “Can I do this at home?”
The answer is: sometimes yes, sometimes no, and the difference matters more than most people realize.
Over the past several years, telehealth ketamine services have exploded in popularity. Companies promise convenient, affordable treatment delivered to your door. And for some patients, this model works beautifully. For others, it can be ineffective at best and genuinely risky at worst.
As someone who has administered ketamine in emergency rooms, urgent care settings, and now in a dedicated clinic environment, I have seen this medicine used in many contexts, from anesthetic to subanesthetic (therapeutic). That range of experience has made me deeply thoughtful about when home-based treatment makes sense and when it simply does not.
Let me walk you through what you actually need to know.
The Core Difference: Route of Administration
When we talk about ketamine therapy at home versus in a clinic, we are really talking about two different medicines. Not chemically. But practically.
At-home ketamine is almost always sublingual or oral. You receive lozenges, troches, or tablets that dissolve under your tongue or are swallowed. Bioavailability through this route runs roughly 20-30%, meaning your body absorbs only a fraction of the dose.
In-clinic ketamine is typically administered intramuscularly (IM) or intravenously (IV). IV ketamine has nearly 100% bioavailability since it enters your bloodstream directly, while IM is close behind with 95% bioavailability. The onset is rapid for both IM and IV, and the experience is more predictable and can be precisely controlled by an experienced physician to maintain absolute physical and psychological safety.
This is not a minor distinction. It shapes the entire treatment experience.
Note: Intranasal esketamine (Spravato) is also provided in-clinic for treatment-resistant depression, and since it is FDA-approved it is carefully controlled as well.
Sublingual ketamine at home can be effective for mood maintenance, mild to moderate depression, and anxiety. But for patients with severe, treatment-resistant depression or active suicidal ideation, the clinical evidence overwhelmingly supports ketamine administration in a supervised setting.
How Telehealth Ketamine Actually Works
If you have seen ads for at-home ketamine, here is the typical process:
- You complete an online intake form and have a video consultation with a prescribing clinician
- If approved, sublingual ketamine is mailed to your home
- You take the medication at home, sometimes with a virtual guide or therapist present via video, sometimes entirely alone
- Follow-up appointments happen periodically by telehealth
This model has genuine advantages. It removes geographic barriers. It can be more affordable than in-person sessions. For patients in rural areas or those with mobility limitations, it opens doors that would otherwise stay closed.
But there are significant limitations.
Without real-time vital sign monitoring, a clinician cannot know if your blood pressure is spiking or your oxygen saturation is dropping. Without in-person observation, subtle signs of dissociation or psychological distress can be missed. And without the contained environment of a clinic, the setting that profoundly influences the ketamine experience is left entirely to chance.
Beyond those health concerns, when patients come to the clinic they are away from the home environment and in a container of safety. They can really surrender and turn OFF. Patients can put their phone away and not worry about getting disturbed by their regular life. By purposefully coming to a clinic for treatment, patients can be entirely present for the healing connection. Although possible to be done over a video call, lots of the connection gets lost when not in-person.
When At-Home Ketamine Can Work Well
I want to be fair to this model because for the right patient, it can be genuinely helpful.
At-home ketamine therapy may be appropriate if you:
- Have mild to moderate depression or anxiety that has not responded fully to traditional medications
- Have already completed an initial series of supervised IV or IM ketamine sessions and are using oral ketamine for maintenance
- Have no history of substance use disorder
- Have no cardiovascular conditions like uncontrolled hypertension
- Have a stable home environment with a trusted person who can be present during sessions
- Are working concurrently with a therapist who can help you integrate insights from the experience
For patients in the Tri-Valley, East Bay, and greater Bay Area who have done foundational work in a clinical setting, transitioning to periodic at-home sessions for maintenance can be a reasonable, cost-effective approach.
The key word is maintenance. This is not about building the foundation. It is about sustaining what has already been built.
When You Absolutely Should Not Do Ketamine at Home
Now for the part that matters most.
There are patients for whom at-home ketamine is not just suboptimal. It is contraindicated. And I worry that the convenience-first marketing of some telehealth services glosses over these realities.
You should not pursue ketamine therapy at home if:
- You have active suicidal ideation. Ketamine has rapid anti-suicidal effects, but this requires precise dosing, monitoring, and immediate access to emergency intervention if needed. A video call is not sufficient safety infrastructure for someone in crisis.
- You have a history of substance use disorder. Ketamine has abuse potential. In a clinic, we control the supply. At home, the entire prescription is in your possession. This is a setup that can go wrong quickly.
- You have uncontrolled hypertension or cardiovascular disease. Ketamine transiently raises blood pressure and heart rate. In a clinic, we monitor vitals and can intervene. At home, a hypertensive crisis could go unnoticed.
- You have a history of psychosis or certain dissociative disorders. Ketamine can induce powerful dissociative states. For most people, this is therapeutic. For someone with a history of psychotic breaks, it can be destabilizing.
- You live alone with no one to supervise sessions. Even at sublingual doses, ketamine impairs coordination and judgment. Having a sober adult present is not optional. It is essential.
- You are seeking ketamine for severe, treatment-resistant depression without prior supervised sessions. Starting this journey unsupervised is like learning to swim in the deep end alone.
If any of these apply to you, please seek in-person care. At our clinic in Livermore, we have the infrastructure to support complex cases safely. That is not a sales pitch. It is simply the clinical reality.
The Safety Considerations No One Talks About
Let me tell you what keeps me up at night about the at-home ketamine boom.
Ketamine is extraordinarily safe when used correctly. In my years working emergency rooms and urgent care, I have administered it countless times for procedural sedation. It has a wide therapeutic margin. Serious adverse events are rare.
But “rare” is not “zero.”
Laryngospasm, though uncommon at sub-anesthetic doses, can occur. Aspiration is possible if someone vomits while dissociated. Severe psychological reactions, while usually manageable with in-person support, can be traumatizing when experienced alone at home.
Then there is the regulatory gray zone. The FDA has approved only Spravato (esketamine nasal spray) for treatment-resistant depression, and it must be administered in a certified healthcare setting with monitoring. All other ketamine use for mental health is off-label. This is not inherently problematic since off-label prescribing is common and often evidence-based. But it means the guardrails are looser, and quality varies wildly between providers.
Some telehealth services are run by conscientious clinicians doing careful work. Others are prescription mills prioritizing volume over safety. As a patient, it can be hard to tell the difference.
What I Recommend to My Patients
When someone comes to Mind Balance Flow asking about at-home ketamine, here is what I tell them:
Start in-person. Do your initial series of treatments where we can monitor your response, adjust dosing in real time, and provide psychological support. Let the medicine do its deep work in a contained, safe environment.
Then, if you are stable and doing well, we can discuss whether periodic at-home maintenance makes sense for your situation. For some patients, it does. For others, continuing in-clinic sessions is the better path.
This is not about control or gatekeeping. It is about respecting what ketamine actually is: a powerful medicine that deserves thoughtful administration.
For those in Livermore, Dublin, Pleasanton, and the wider Bay Area, in-person care is genuinely accessible. You do not have to choose convenience over safety.
Ketamine therapy at home is not inherently good or bad. It is a tool that works for some situations and not others.
If you are stable, have already done supervised treatment, and are using low-dose sublingual ketamine for maintenance under the guidance of a thoughtful clinician, at-home therapy can be a reasonable choice.
If you are dealing with severe depression, suicidal thoughts, substance use history, or cardiovascular issues, please seek in-person care. The convenience of home treatment is not worth the risk.
And if you are unsure where you fall, that uncertainty itself is a reason to start with supervision. You can always move toward more independence later. You cannot undo a bad outcome.
If you are in the Tri-Valley or Bay Area and want to discuss whether ketamine therapy might help you, I offer free virtual consultations at Mind Balance Flow. No pressure, no obligations. Just an honest conversation about what might actually serve your healing.
Sources
- Yanagihara Y, Ohtani M, Kariya S, et al. Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers. Biopharmaceutics & Drug Disposition. 2003;24(1):37-43. doi:10.1002/bdd.336
- Bahji A, Vazquez GH, Zarate CA Jr. Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis. Journal of Affective Disorders. 2021;278:542-555. doi:10.1016/j.jad.2020.09.071
- Wilkinson ST, Ballard ED, Bloch MH, et al. The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis. American Journal of Psychiatry. 2018;175(2):150-158. doi:10.1176/appi.ajp.2017.17040472
- U.S. Food and Drug Administration. FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor’s office or clinic. FDA News Release. March 5, 2019. https://www.fda.gov/news-events/press-announcements/fda-approves-new-nasal-spray-medication-treatment-resistant-depression-available-only-certified






